CVspectrum.org
GO TO: Register Now! SIGN IN



SEARCH


Advanced Search >>
BROWSE





Dyslipidemia

News

Featured Slide

Editorial

  • How Low Can You Go . . . Safely?
    Stephen D. Wiviott, MD

    The benefits of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been observed in major primary2-4 and secondary3-7 prevention trials across a wide range of cholesterol levels in stable patients.

Continuing Education

CVspectrum.org

Annenberg Center for Health Sciences      Supported by educational grants from Abbott Laboratories, Daiichi-Sankyo, Inc., and Eli Lilly and Company.
Supported by an educational grant from Molecular Insight Pharmaceuticals, Inc.
Molecular Insights
Independent Medical Education © Copyright 2012 CVspectrum.org.      About CVspectrum | Terms of Use | Privacy Policy | Site Map | Contact Us